
|Articles|May 5, 2015
Quintiles Opens Bioanalytical Lab in Europe
Author(s)News Update
May 5, 2015.
Advertisement
Quintiles has announced the expansion of its bioanalytical laboratory services with the establishment of a GLP-compliant bioanalytical liquid chromatography-mass spectrometry (LC-MS) laboratory. The laboratory, which is located in Oss, the Netherlands, will have extensive bioanalytical testing capabilities and will provide a European facility for customers to conduct pharmacokinetics studies.
Currently, Quintiles’ bioanalytical capabilities and work are managed out of three laboratory sites in the U.S. The new laboratory will be integrated with Quintiles’ existing laboratory in Ithaca, New York, enabling the transfer of assays back and forth to accommodate global studies.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
2
The Evolving Relationship Between FDA and Biotech
3
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
4
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
5




